Wikipedia -WSS

Wikipedia

author：comprehensive 2025-09-28 23:50:46 - browse：7382

Treeline Northwest — AP Photo/Ted S. Warren

Josh Bilenker’s last company, Loxo Oncology, was purchased by Eli Lilly for $8 billion. No surprise, then, that his next effort has already raised at least $473 million in funding from private investors even before telling the public what, exactly, it is working on.

Treeline Biosciences, the new venture by Bilenker and Jeffrey Engelman, formerly Novartis’s top cancer researcher, has hired more than 130 people across three research sites in little more than a year, according to a company blog post, regulatory filings, and STAT reporting.

Treeline’s website doesn’t mention a single drug target or disease. In a paper published last year in Nature Cancer, Engelman and several colleagues reviewed the history of a class of cancer drugs called PI3 kinase inhibitors.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： How to save PrEP access — and even expand it
Next article： How CO2 helps viruses stay alive longer in the air

WSS

Cytokinetics CEO stresses company can launch heart drug on its own

Structure Therapeutics oral GLP

Wellcome Trust’s new CEO hopes Big Tech gets more involved in public health

Glen Campbell's doctor discusses his public struggle with Alzheimer's

Helping hospitals and community health centers plan for resilience

BD to buy Edwards patient monitoring unit for $4.2 billion

hotspot

Wikipedia

Wikipedia

Sports medicine is finally prioritizing gender equality

Congress needs to close a vaccine

Peter Hotez and the public health issue of online harassment

Structure Therapeutics oral GLP

Activists slam private health insurers over coverage restrictions

ASCO Takeaways: Winners, snoozers, and the art of cancer care

Medicare proposal to cover medical devices draws a mixed reaction

It's time to retire 'poor historian' from clinicians' vocabularies

DIEP, the 'gold standard' of breast reconstruction, is under threat

Anxious about a speech? A startup wants you to pop a minty cardiac drug

focus

Arc Institute generative AI designs new CRISPR systems

Readers respond to H5N1 and livestock movements, and more

For pregnant people, addiction treatment shouldn't mean a call to child protective services

NVIDIA and Google execs on the future of AI and drug discovery

The most pressing bird flu mysteries scientists want answered

Military medical care influenced by rank and race, new study finds

focus

hotspot

focus

Wikipedia